ULBI

Ultralife Corporation
NASDAQINDUSTRIALSELECTRICAL EQUIPMENT & PARTS

Key Statistics

Market Cap
$260.96M
P/E Ratio
—
EPS
$-0.38
Beta
0.61
52W High
$15.69
52W Low
$4.90
50-Day MA
$7.60
200-Day MA
$6.70
Dividend Yield
—
Profit Margin
-3.50%
Forward P/E
15.34
PEG Ratio
3.81

About Ultralife Corporation

Ultralife Corporation designs, manufactures, installs and maintains electrical, communication and electronic systems worldwide. The company is headquartered in Newark, New York.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$187.24M
Gross Profit (TTM)$45.65M
EBITDA$12.73M
Operating Margin9.01%
Return on Equity-4.91%
Return on Assets2.10%
Revenue/Share (TTM)$11.24
Book Value$7.95
Price-to-Book1.97
Price-to-Sales (TTM)1.39
EV/Revenue1.595
EV/EBITDA149.65
Quarterly Earnings Growth (YoY)200.00%
Quarterly Revenue Growth (YoY)-1.30%
Shares Outstanding$16.66M
Float$9.83M
% Insiders3.22%
% Institutions73.60%

Historical Volatility

HV 10-Day
27.33%
HV 20-Day
39.17%
HV 30-Day
36.27%
HV 60-Day
54.43%
HV Rank
11.9%

Volatility is currently contracting

Latest News

Ultralife Corporation Reports Third Quarter Results

NEWARK, N.Y., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2026 with the following results:

GlobeNewsWire11/5/2026Neutral
EnerSys To Acquire Ultralife, Expanding Differentiated Battery Technologies and Accelerating Growth in Defense Market

READING, Pa.--(BUSINESS WIRE)-- #EnerSys--EnerSys (NYSE: ENS), a global leader in stored energy solutions for industrial, infrastructure, and defense applications, today announced that it has entered into a definitive agreement to acquire Ultralife (NASDAQ:ULBI) for $16.00 per share in cash, representing a 166% premium to Ultralife's unaffected closing share price on October 26, 2026. The transaction represents an enterprise value of approximately $320 million. EnerSys expects to realize $15 million to $2.

Business Wire10/27/2026Neutral
EnerSys to Acquire Ultralife Corporation in a $320 Million All-Cash Transaction

NEWARK, N.Y., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has entered into an Agreement and Plan of Merger (“merger agreement”) with EnerSys (NYSE: ENS) under which upon closing EnerSys will acquire Ultralife Corporation in an all-cash transaction valued at approximately $320 million, including the assumption of net debt.

GlobeNewsWire10/27/2026Neutral
Ultralife Q2 Earnings Call Highlights

Ultralife NASDAQ: ULBI reported second-quarter 2026 revenue of $47.9 million, operating income of $3.4 million and diluted earnings per share of $0.15, as the company cited stronger gross margins, a record backlog and continued investment in product development across its battery and communications businesses.

MarketBeat8/7/2026Positive
Ultralife Corporation Reports Second Quarter Results

NEWARK, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: Sales of $47.9 million compared to $48.6 million for the 2025 second quarter Gross profit of $13.9 million, or 28.9% of revenue, compared to $11.6 million, or 23.9% of revenue, for the 2025 second quarter; excluding a $1.1 million net IEEPA refund received in the 2026 second quarter, gross margin was 26.6% Operating income of $3.4 million, including one-time costs of $0.9 million, compared to $2.3 million including one-time costs of $0.3 million for the 2025 second quarter GAAP EPS of $0.15 compared to $0.05 for the 2025 second quarter Adjusted EBITDA of $6.1 million compared to $4.1 million for the 2025 second quarter Backlog of $117.5 million compared to $115.1 million exiting the first quarter of 2026 “For the second quarter we delivered a 760-basis point improvement in gross profit margin compared to the first quarter, including the contribution of the net IEEPA refund.

GlobeNewsWire8/7/2026Neutral
Zacks Initiates Coverage of Ultralife With Underperform Recommendation

Discover why Zacks rates Ultralife as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore ULBI's struggles with execution risks, margin pressure and commercialization delays that could delay its earnings recovery.

Zacks Investment Research7/16/2026Negative
Ultralife Q1 Earnings Call Highlights

Ultralife NASDAQ: ULBI reported a first-quarter loss for fiscal 2026 as lower sales, production disruptions and higher one-time costs weighed on results, even as management pointed to a record backlog and new product activity as signs of future growth.

MarketBeat5/9/2026Negative

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ULBI and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More INDUSTRIALS Stocks

Data last updated: 11/7/2026